JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, C. J.
Right arrow Articles by Scatton, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, C. J.
Right arrow Articles by Scatton, B.

Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex

CJ Carter, KG Lloyd, B Zivkovic and B Scatton

Synthelabo Recherche, Biology Department, Bagneux, France.

Ifenprodil and SL 82.0715 are noncompetitive N-methyl-D-aspartate (NMDA) antagonists whose inhibitory actions are not explained by antagonistic effects at any of the three commonly recognized sites within the NMDA receptor complex (recognition, channel and modulatory glycine sites). We presently show that ifenprodil and SL 82.0715 antagonize the effects of NMDA via a selective action at the recently described polyamine modulatory site. Spermine and spermidine (0.5-100 microM) increase the binding of [3H]1-[1-(2-thienyl)cyclohexyl] piperidine to washed rat forebrain membranes in the presence of glutamate (10 microM). This effect is antagonized by ifenprodil and SL 82.0715 (0.1-10 microM) at concentrations which do not displace [3H]1- (2-thienyl)cyclohexyl] piperidine in the absence of added polyamine. Spermine and spermidine (up to 100 microM) do not significantly alter the binding of [3H]glycine but increase the binding of the NMDA recognition site ligand [3H](+/-)-3-(2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid. Ifenprodil and SL 82.0715 (0.1-10 microM) antagonize this effect; ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5- 10-imine maleate) or 7-chlorokynurenate (100 microM) are ineffective. In immature rat cerebellar slices, spermine and spermidine (10-1000 microM) potentiate the maximal effects of NMDA (80-160 microM) on cyclic GMP production. Spermine (100-1000 microM) reverses the antagonistic effects of ifenprodil (0.15-50 microM) but not of ((+)-5- methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-10-imine acid or kynurenate on the NMDA receptor-mediated increase in cyclic GMP levels. Ifenprodil (0.01-1 microM) potently but only partially antagonizes the depolarizing effects of NMDA (10 microM) on the immature rat spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 253, Issue 2, pp. 475-482, 05/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Malherbe, V. Mutel, C. Broger, F. Perin-Dureau, J. A. Kemp, J. Neyton, P. Paoletti, and J. N. C. Kew
Identification of Critical Residues in the Amino Terminal Domain of the Human NR2B Subunit Involved in the RO 25-6981 Binding Pocket
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Masuko, T. Kuno, K. Kashiwagi, T. Kusama, K. Williams, and K. Igarashi
Stimulatory and Inhibitory Properties of Aminoglycoside Antibiotics at N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1026 - 1033.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. L. Berger and P. Rebernik
Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1584 - 1591.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Keefe and A. C. Adams
Differential Effects of N-Methyl-D-Aspartate Receptor Blockade on Eticlopride-Induced Immediate Early Gene Expression in the Medial and Lateral Striatum
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1076 - 1083.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. L. Coughenour and J. J. Cordon
Characterization of Haloperidol and Trifluperidol as Subtype-Selective N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Using [3H]TCP and [3H]Ifenprodil Binding in Rat Brain Membranes
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 584 - 592.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. J. Gallagher, H. Huang, D. B. Pritchett, and D. R. Lynch
Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor
J. Biol. Chem., April 19, 1996; 271(16): 9603 - 9611.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
M. D. Ginsberg
REVIEW {blacksquare} : Neuroprotection in Brain Ischemia: An Update (Part I
Neuroscientist, March 1, 1995; 1(2): 95 - 103.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.